Event: OTC Derivatives Summit Asia 2017: 20% Discount for OTC Space Readers

20 February 2017 | Samantha Hodgson

OTC Derivatives Summit Asia 2017

Thursday 16th March 2017: Singapore

Since Regulation Asia’s last OTC Derivatives Summit, new uncertainties have emerged. Extant challenges—such as banks’ struggle for profitability amid shrinking balance sheets and increasingly burdensome capital adequacy requirements—appear no closer to being resolved. A seeming lack of regulatory coordination, exemplified by Hong Kong, Singapore and Australia not carrying through with the 1 September deadline for initial margin, has only added to the problem. This raft of uncertainties means that one year on, it has become harder, not less difficult, to predict how Asia-Pacific’s OTC derivatives markets will evolve. Yet it also means the imperative to attempt to understand where we stand, and where we're going, has become even stronger.

Speakers will include:

  • ANDREA SCHNOZ: Head of Asia Finance Regulatory Policy, Barclays
  • AVE KING: Executive Director, Regional Compliance for F&O and OTC Clearing, J.P. Morgan

To read the full article, please:

Log in Register